| Sources | Names Used |
|---|---|
| CTRPv2 | triazolothiadiazine |
| PharmacoGx | triazolothiadiazine |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNRNP40 | CTRPv2 | pan-cancer | AAC | 0.21 | 9e-12 |
| mRNA | CHAF1A | CTRPv2 | pan-cancer | AAC | 0.23 | 9e-12 |
| mRNA | SYNCRIP | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-11 |
| mRNA | RIOK1 | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-11 |
| mRNA | DAZAP1 | CTRPv2 | pan-cancer | AAC | 0.24 | 2e-11 |
| mRNA | HDAC2 | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-11 |
| mRNA | FAM114A1 | CTRPv2 | pan-cancer | AAC | -0.24 | 3e-11 |
| mRNA | NASP | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-11 |
| mRNA | SAFB | CTRPv2 | pan-cancer | AAC | 0.22 | 5e-11 |
| mRNA | RFX7 | CTRPv2 | pan-cancer | AAC | 0.22 | 6e-11 |
